Business Context and Reporting Period
This Form 8-K was filed by UnumProvident Corporation on September 20, 2006. The report addresses a corporate governance disclosure deficiency identified by the New York Stock Exchange (NYSE) regarding the identification of the director presiding over executive sessions of non-management directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a current report regarding a listing standard compliance issue and contains no financial performance data.
Material Changes
There are no material changes to financial operations or business strategy reported. The material event is the receipt of a notice from the NYSE on September 20, 2006, stating the company was deficient in meeting Section 303A.03 of the NYSE Listed Company Manual. The company has concurrently filed this 8-K to cure the deficiency by providing the required disclosure.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary on future financial performance. The primary risk addressed was the potential failure to satisfy a continued listing rule, which the company states has been cured as of the filing date. No unusual items or contingencies are disclosed.
Investor Verification Points
- Verify that the company's proxy statement or subsequent filings now explicitly name the director chosen to preside at executive sessions of non-management directors.
- Confirm the company's continued compliance with NYSE corporate governance standards following this cure.
- Note that this filing does not contain financial results; refer to the most recent 10-Q or 10-K for financial metrics.